R.Ph.s say AMP rule will drive them out of Medicaid

Article

In a poll of its members, NCPA reported that 86% of community pharmacies stated that the proposed rule governing Medicaid reimbursement for generic drugs would drive them out of the program. The Medicaid program currently bases its federal upper limit (FUL) calculations on average wholesale price (AWP), but under the Deficit Reduction Act of 2005, the agency was directed to change the rate to 250% of the average manufacturers price (AMP). NCPA officials worry that the new ruling may force many community pharmacies out of business and restrict access to medications in many rural and poor urban communities. Citing a GAO report that found that under the rule Medicaid would pay retail pharmacists on average 36% less than their acquisition costs, NCPA executive VP/CEO Bruce Roberts commented: "What we're faced with is not a natural disaster but a public policy disaster."

To see more Hot off the Press news articles, click here.

To go to the Drug Topics homepage, click here.

Newsletter

Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.

Recent Videos
2 experts are featured in this series.
2 experts are featured in this series.
2 experts are featured in this series.
2 experts are featured in this series
Image Credit: jokekung - stock.adobe.com
Related Content
© 2025 MJH Life Sciences

All rights reserved.